GCP
TMDX icon

GSA Capital Partners’s Transmedics TMDX Stock Holding History

GSA Capital Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,745
Closed -$273K – 2171
2026
Q1 		$273K Buy
2,745
+512
+23% +$66.8K 0.02% 1303
2025
Q4 		$272K Sell
2,233
-3,748
-63% -$470K 0.02% 1224
2025
Q3 		$671K Buy
+5,981
New +$700K 0.06% 655
2025
Q2 		– Sell
-6,425
Closed -$432K – 2148
2025
Q1 		$432K Sell
6,425
-1,273
-17% -$87.6K 0.04% 900
2024
Q4 		$480K Buy
+7,698
New +$717K 0.04% 930
2024
Q3 		– Sell
-7,969
Closed -$1.2M – 2009
2024
Q2 		$1.2M Buy
+7,969
New +$956K 0.08% 390
2022
Q1 		– Sell
-33,499
Closed -$642K – 1831
2021
Q4 		$642K Buy
+33,499
New +$840K 0.08% 440

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

GSA Capital Partners's TMDX Position: Q2 2026 in Review

GSA Capital Partners sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,745 shares — an estimated $273K sold.

GSA Capital Partners first reported a position in TMDX in Q4 2021 and held it in 7 quarters. The position peaked at $1.2M in Q2 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • GSA Capital Partners reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 2,745 Transmedics shares in Q2 2026, an estimated $273K.
  • GSA Capital Partners first reported a position in Transmedics in Q4 2021 and held it in 7 quarters.
  • GSA Capital Partners's Transmedics position peaked at $1.2M in Q2 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.